VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.

Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio MS, Waschek JA, Tan YV

Open source

DOI
10.1186/s12974-016-0626-3
Published
2016 Jun 29
Container
Journal of neuroinflammation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12974-016-0626-3,
  title = {VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.},
  author = {Abad C and Jayaram B and Becquet L and Wang Y and O'Dorisio MS and Waschek JA and Tan YV},
  year = {2016},
  journal = {Journal of neuroinflammation},
  doi = {10.1186/s12974-016-0626-3},
  url = {https://doi.org/10.1186/s12974-016-0626-3}
}

RIS

TY  - JOUR
TI  - VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
AU  - Abad C
AU  - Jayaram B
AU  - Becquet L
AU  - Wang Y
AU  - O'Dorisio MS
AU  - Waschek JA
AU  - Tan YV
PY  - 2016
JO  - Journal of neuroinflammation
DO  - 10.1186/s12974-016-0626-3
UR  - https://doi.org/10.1186/s12974-016-0626-3
ER  - 

APA

C, A., B, J., L, B., Y, W., MS, O., JA, W., & YV, T. (2016). VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.. Journal of neuroinflammation. https://doi.org/10.1186/s12974-016-0626-3

Source records